OPERATING REVIEW
Quality & Patient Experience
October 2026

Quality Is a Growth Strategy

Quality is part of the clinical product. Stronger clinical performance builds trust with patients, physicians and employees, and that trust can become an important foundation for growth.

Physician and nurse talking with a patient at the bedside.
Healthcare strategy extends beyond the hospital campus.

Healthcare organizations usually talk about quality and growth as separate agendas. Quality belongs to clinical leadership. Growth belongs to strategy and business development. One team focuses on outcomes, safety and reliability while another thinks about market share, service lines, physician recruitment and access.

But patients and physicians don't experience the organization that way. Quality is part of the product. And over time, the quality of that product helps determine whether people choose it.

I saw this clearly in Bakersfield. When I arrived, the hospital had significant quality challenges. We were dealing with regulatory issues, inconsistent performance and a level of physician confidence that needed to improve. At the same time, we had ambitious growth objectives in a market where our largest competitor operated multiple hospitals.

56% → 72%
Primary service area market share in Sonora

It would have been easy to treat those as sequential problems: fix quality first, then pursue growth. We didn't. Improving quality was part of the growth strategy.

We strengthened clinical processes, accountability and operating discipline. Over time, the hospital moved from a Leapfrog C to an A, earned Healthgrades recognition for clinical excellence in the top 5% nationally, and received U.S. News recognition for performance in selected areas of common care.

Those results mattered clinically. They also changed what became possible strategically.

Physicians are more willing to build programs in hospitals where they trust the clinical environment. Employees are more likely to take pride in an organization they believe is delivering excellent care. Patients are more likely to choose a hospital they believe will take good care of them. And a stronger reputation gives the organization greater credibility when recruiting physicians, developing service lines and asking the community to choose it for increasingly complex care.

That creates a reinforcing cycle. Better clinical performance builds confidence. Confidence strengthens physician relationships and organizational culture. Stronger physician relationships support clinical growth. Growth creates resources that can be reinvested in people, technology and clinical capability. Those investments can improve the product further.

The same principle played out differently in Sonora. There, the competitive challenge wasn't primarily another hospital. It was outmigration.

Patients routinely left the community for care in larger markets. Building market share required more than marketing the hospital more aggressively. We had to give patients and physicians credible reasons to believe more care could be delivered well close to home.

That meant developing stronger clinical capabilities in areas such as cancer, cardiovascular care, imaging and surgery. But capability alone wasn't enough. The community had to trust it.

As clinical capabilities expanded, we became much more deliberate about communicating the quality of care available locally. Patient stories were particularly powerful because they turned an abstract claim about quality into something the community could understand: people they knew had faced serious medical problems and received excellent care close to home.

During that period, perceptions of hospital quality improved substantially, community preference strengthened, and primary service area market share increased from 56% to 72%.

Quality is one of the ways an organization earns trust. And trust has economic consequences.

The lesson isn't that quality improvement automatically produces market share. Markets are more complicated than that. Access matters. Physician supply matters. Capacity matters. Payer relationships matter. Consumer preference matters. Competitors respond. But quality influences nearly all of them.

That's why I think healthcare leaders should be cautious about treating quality primarily as a compliance obligation or a collection of metrics reported to the board. Quality is one of the ways an organization earns trust. And trust has economic consequences.

A physician deciding where to practice or where to take a patient is making a judgment about trust. A patient deciding whether to receive care locally or travel elsewhere is making a judgment about trust. An employee deciding whether to recommend the organization to a family member is making a judgment about trust.

Those individual decisions accumulate. Eventually they show up in physician recruitment, retention, service-line growth, patient preference, market share and financial performance.

This doesn't mean quality should be pursued because it produces growth. The first obligation is still to provide excellent care because patients deserve excellent care. But leaders shouldn't miss the strategic consequence.

When evaluating a growth opportunity, one of the most important questions may be: Is the clinical product strong enough to support the growth we're trying to create? And if it isn't: What would have to be true clinically for physicians and patients to choose us?

Quality, growth, culture, physician alignment and financial performance are not separate leadership agendas. They reinforce one another. The strongest growth strategy may begin long before the marketing campaign or the business plan. It may begin with making the clinical product better.

OPERATING REVIEW

More thinking from the operating side of healthcare.

Strategy, operations, quality, physicians, people, and performance—examined as parts of one interconnected system.

Return to Operating Review →